Categories AlphaGraphs, Earnings, Health Care

Earnings: Highlights of Eli Lilly & Company’s (LLY) Q1 2023 results

Eli Lilly and Company (NYSE: LLY) on Thursday reported lower earnings and revenues for the first quarter of 2023. The company also provided guidance for fiscal 2023.

Eli Lilly Q1 2023 earnings infographic

The Indianapolis-based pharmaceutical company said its revenues declined 11% year-over-year to $6.96 billion in the first quarter, hurt by lower realized prices and a decline in volumes.

The weak top-line performance translated into a 38% fall in net earnings, on an adjusted basis, to $1.62 per share. Unadjusted profit decreased to $1.34 billion or $1.49 per share from $1.90 billion or $2.10 per share in the first quarter of 2022.

“Core business growth drove solid first-quarter financial results and a strong start for Lilly in 2023, which includes pipeline progress led by positive SURMOUNT-2 data for tirzepatide in obesity,” said David Ricks, CEO of Eli Lilly.

Prior Performance

  • Eli-Lilly-Q4-2022-Earnings-Infographic
  • Eli Lilly Q3 2022 earnings infographic
  • Eli-Lilly-Q2-2022-Earnings-Infographic
  • Eli Lilly Q1 2022 earnings infographic

Most Popular

Take-Two Interactive Software (TTWO): Key takeaways from the Q4 2024 earnings report

Shares of Take-Two Interactive Software, Inc. (NASDAQ: TTWO) stayed green on Friday. The stock has gained 7% over the past 12 months. The company reported its fourth quarter 2024 earnings

Take-Two Interactive Software (TTWO) Earnings: 4Q24 Key Numbers

Take-Two Interactive Software, Inc. (NASDAQ: TTWO) reported net revenue of $1.40 billion for the fourth quarter of 2024, which was down 3% year-over-year. Net loss was $2.90 billion, or $17.02

Applied Materials (AMAT) Earnings: 2Q24 Key Numbers

Applied Materials, Inc. (NASDAQ: AMAT) reported revenue of $6.65 billion for the second quarter of 2024, which remained flat year-over-year. GAAP net income increased 9% to $1.72 billion and EPS

Add Comment
Viewing Highlight